156 related articles for article (PubMed ID: 21413009)
1. Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.
Lukanova A; Surcel HM; Lundin E; Kaasila M; Lakso HA; Schock H; Husing A; Kaaks R; Koskela P; Grankvist K; Pukkala E; Zeleniuch-Jacquotte A; Lehtinen M; Toniolo P
Int J Cancer; 2012 Feb; 130(4):910-20. PubMed ID: 21413009
[TBL] [Abstract][Full Text] [Related]
2. Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort.
Fortner RT; Tolockiene E; Schock H; Oda H; Lakso HÅ; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A; Grankvist K; Lundin E
Breast Cancer Res; 2017 Jul; 19(1):82. PubMed ID: 28720108
[TBL] [Abstract][Full Text] [Related]
3. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
4. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone levels during pregnancy and incidence of maternal breast cancer.
Peck JD; Hulka BS; Poole C; Savitz DA; Baird D; Richardson BE
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):361-8. PubMed ID: 11927496
[TBL] [Abstract][Full Text] [Related]
6. Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.
Fortner RT; Schock H; Kaaks R; Lehtinen M; Pukkala E; Lakso HÅ; Tanner M; Kallio R; Joensuu H; Grankvist K; Zeleniuch-Jacquotte A; Toniolo P; Lundin E; Surcel HM
Cancer Res; 2014 Dec; 74(23):6958-67. PubMed ID: 25281720
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
[TBL] [Abstract][Full Text] [Related]
8. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
9. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.
Eliassen AH; Spiegelman D; Xu X; Keefer LK; Veenstra TD; Barbieri RL; Willett WC; Hankinson SE; Ziegler RG
Cancer Res; 2012 Feb; 72(3):696-706. PubMed ID: 22144471
[TBL] [Abstract][Full Text] [Related]
10. Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.
Fortner RT; Schock H; Kaaks R; Lehtinen M; Pukkala E; Lakso HÅ; Tanner M; Kallio R; Joensuu H; Korpela J; Toriola AT; Hallmans G; Grankvist K; Zeleniuch-Jacquotte A; Toniolo P; Lundin E; Surcel HM
Cancer Res; 2017 Jan; 77(1):134-141. PubMed ID: 27784743
[TBL] [Abstract][Full Text] [Related]
11. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
[TBL] [Abstract][Full Text] [Related]
12. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
[TBL] [Abstract][Full Text] [Related]
15. Estrogen metabolism and risk of breast cancer in postmenopausal women.
Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
17. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
18. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
[TBL] [Abstract][Full Text] [Related]
19. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
[TBL] [Abstract][Full Text] [Related]
20. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
